MAPT and Alzheimer disease: These alterations disrupt microglial homeostasis, impair their ability to clear amyloid‐beta plaques and tau protein aggregates, and contribute to the progression of neurodegenerative diseases such as Alzheimer's disease (AD) (Uddin and Lim 2022).